We are live on
!
Find out more
WA
Wasatch Advisors Portfolio holdings
AUM
$15.3B
1-Year Est. Return
25.06%
This Fund
S&P 500
This Quarter
Est. Return
+8.33%
1 Year Est. Return
+25.06%
3 Year Est. Return
+87.66%
5 Year Est. Return
+80.4%
10 Year Est. Return
+874.7%
AUM
$16.5B
AUM Growth
+$455M
(+2.8%)
Cap. Flow
-$513M
Cap. Flow
% of AUM
-3.11%
Top 10 Holdings %
Top 10 Hldgs %
23.61%
Holding
273
New
16
Increased
90
Reduced
147
Closed
16
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Globant
GLOB
|
+$75.4M |
| 2 |
SILK
Silk Road Medical, Inc. Common Stock
SILK
|
+$73.1M |
| 3 |
Certara
CERT
|
+$56.7M |
| 4 |
Shift4
FOUR
|
+$40.8M |
| 5 |
Fox Factory Holding Corp
FOXF
|
+$39.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ABCM
Abcam PLC
ABCM
|
+$110M |
| 2 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$62M |
| 3 |
Medpace
MEDP
|
+$60.2M |
| 4 |
The Ensign Group
ENSG
|
+$53M |
| 5 |
Valvoline
VVV
|
+$52.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.67% |
| 2 | Healthcare | 18.3% |
| 3 | Consumer Discretionary | 16.93% |
| 4 | Industrials | 14.53% |
| 5 | Financials | 12.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Globant
GLOB
$1.68B
| $538M | 3.26% |
2,994,433
+459,850
| +18% | +$75.4M |
|
|
2
The Ensign Group
ENSG
$10.6B
| $452M | 2.73% |
4,730,487
-563,322
| -11% | -$53M |
|
3
HealthEquity
HQY
$8.73B
| $450M | 2.72% |
7,128,322
-584,267
| -8% | -$33.9M |
|
|
NVMI
4
Nova
NVMI
$12B
| $417M | 2.52% |
3,552,045
+75,479
| +2% | +$7.72M |
|
|
5
Medpace
MEDP
$16.4B
| $377M | 2.28% |
1,568,901
-289,753
| -16% | -$60.2M |
|
|
CYBR
6
DELISTED
CyberArk
CYBR
| $343M | 2.08% |
2,196,120
-172,548
| -7% | -$24.7M |
|
7
Trex
TREX
$4.45B
| $340M | 2.06% |
5,180,942
-859,009
| -14% | -$47.9M |
|
8
Five Below
FIVE
$11.9B
| $339M | 2.05% |
1,725,811
-72,471
| -4% | -$14.2M |
|
9
FIVE9
FIVN
$2.13B
| $323M | 1.96% |
3,919,153
+330,256
| +9% | +$22.2M |
|
|
10
Fox Factory Holding Corp
FOXF
$805M
| $322M | 1.95% |
2,963,714
+381,845
| +15% | +$39.1M |
|
11
RBC Bearings
RBC
$17.6B
| $317M | 1.92% |
1,458,108
-40,450
| -3% | -$8.77M |
|
12
Bank OZK
OZK
$5.64B
| $313M | 1.89% |
7,784,912
-476,605
| -6% | -$17.1M |
|
13
Kadant
KAI
$3.57B
| $292M | 1.77% |
1,313,152
-138,685
| -10% | -$27.8M |
|
14
Hamilton Lane
HLNE
$3.9B
| $282M | 1.71% |
3,525,646
-169,212
| -5% | -$12.2M |
|
15
Paylocity
PCTY
$7.85B
| $277M | 1.68% |
1,501,674
+39,646
| +3% | +$7.26M |
|
16
Euronet Worldwide
EEFT
$3.17B
| $275M | 1.67% |
2,343,667
-210,121
| -8% | -$23.5M |
|
17
Floor & Decor
FND
$6.07B
| $269M | 1.63% |
2,591,362
-277,105
| -10% | -$26.5M |
|
18
Helios Technologies
HLIO
$2.52B
| $269M | 1.63% |
4,064,217
-239,982
| -6% | -$14.2M |
|
|
BCPC
19
Balchem Corp
BCPC
$5.26B
| $267M | 1.62% |
1,983,484
-86,032
| -4% | -$11.1M |
|
20
Saia
SAIA
$10.4B
| $267M | 1.61% |
778,397
-79,820
| -9% | -$23.1M |
|
21
Neogen
NEOG
$2.04B
| $258M | 1.56% |
11,864,374
-2,277,963
| -16% | -$41.2M |
|
22
Ollie's Bargain Outlet
OLLI
$4.37B
| $242M | 1.47% |
4,183,040
-444,030
| -10% | -$27.4M |
|
23
XPEL
XPEL
$1.22B
| $236M | 1.43% |
2,796,782
+311,957
| +13% | +$23.1M |
|
24
Guidewire Software
GWRE
$14.1B
| $223M | 1.35% |
2,933,445
+356,153
| +14% | +$27.3M |
|
|
ITCI
25
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $221M | 1.34% |
3,485,019
-994,557
| -22% | -$62M |
|
Similar funds
UM
RFC
MSV
IA
NMO
AT
Wasatch Advisors's Q2 2023 Portfolio in Review
As of Q2 2023, Wasatch Advisors held 273 positions worth $16.5B, up 2.8% from $16.1B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Wasatch Advisors withdrew a net $513M in Q2 2023, closing 16 positions and reducing 147 holdings. Its most notable exit was Abcam PLC, an estimated $110M position sold in full.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Wasatch Advisors opened a new position in Certara worth $48.9M.
- Wasatch Advisors's largest Q2 2023 buy was Certara: 2,686,675 shares worth $48.9M.
- Wasatch Advisors added most to Globant in Q2 2023, an estimated $75.4M increase.
- Wasatch Advisors's biggest Q2 2023 reduction was Intra-Cellular Therapies Inc., cutting an estimated $62M.
- Wasatch Advisors fully exited Abcam PLC in Q2 2023, selling an estimated $110M.
- Wasatch Advisors's ten largest holdings make up 24% of its $16.5B portfolio in Q2 2023.
- Wasatch Advisors opened 16 new positions and closed 16 in Q2 2023.
- Wasatch Advisors's portfolio value rose 2.8% quarter-over-quarter to $16.5B.
Based on Wasatch Advisors's 13F filing for Q2 2023, filed 8 Aug 2023.